We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-14.83%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$5.16B
AUM Growth
-$1.15B
Cap. Flow
+$52.2M
Cap. Flow %
1.01%
Top 10 Hldgs %
40.75%
Holding
232
New
16
Increased
80
Reduced
52
Closed
17

Top Buys

Rank Stock Value
1
BDTX icon
Black Diamond Therapeutics
BDTX
+$40.5M
2
FATE icon
Fate Therapeutics
FATE
+$37.4M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$29.7M
4
ESPR
Esperion Therapeutics
ESPR
+$27.1M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$25.4M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$63.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$54M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$26.7M
4
MRNA icon
Moderna
MRNA
+$22.7M
5
ALGN icon
Align Technology
ALGN
+$18.1M

Sector Composition

Rank Sector Weight
1 Healthcare 95.76%
2 Technology 0.56%
3 Industrials 0.54%
4 Communication Services 0.17%
5 Financials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNDM icon
76
Tandem Diabetes Care
TNDM
$1.17B
$12.6M 0.24%
195,038
-5,109
-3% -$358K
RMD icon
77
ResMed
RMD
$28.9B
$11.6M 0.22%
78,505
+2,695
+4% +$429K
AMED
78
DELISTED
Amedisys
AMED
$11.2M 0.22%
61,143
+7,778
+15% +$1.38M
TMO icon
79
Thermo Fisher Scientific
TMO
$198B
$11.2M 0.22%
39,552
-25,245
-39% -$7.96M
QDEL icon
80
QuidelOrtho
QDEL
$1.19B
$11.1M 0.22%
113,955
-223,573
-66% -$18.1M
TRHC
81
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$10.9M 0.21%
208,809
+7,174
+4% +$388K
IRTC icon
82
iRhythm Holdings
IRTC
$3.64B
$10.8M 0.21%
133,259
-3,304
-2% -$274K
GILD icon
83
Gilead Sciences
GILD
$167B
$10.8M 0.21%
144,500
+136,000
+1,600% +$9.4M
SWAV
84
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$10.8M 0.21%
324,661
+113,903
+54% +$4.52M
CHNG
85
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$10.8M 0.21%
1,077,575
+213,653
+25% +$2.99M
ZBH icon
86
Zimmer Biomet
ZBH
$17.6B
$10.6M 0.21%
107,977
-113,506
-51% -$14.9M
IDXX icon
87
Idexx Laboratories
IDXX
$44.8B
$10.2M 0.2%
41,911
-5,550
-12% -$1.45M
SUPN icon
88
Supernus Pharmaceuticals
SUPN
$2.79B
$9.95M 0.19%
552,800
-22,800
-4% -$479K
GNMK
89
DELISTED
GenMark Diagnostics, Inc
GNMK
$9.94M 0.19%
2,411,926
-29,315
-1% -$137K
REGN icon
90
Regeneron Pharmaceuticals
REGN
$70.9B
$9.33M 0.18%
19,100
-2,900
-13% -$1.2M
IART icon
91
Integra LifeSciences
IART
$1.5B
$8.82M 0.17%
197,420
-60,352
-23% -$3.17M
INSP icon
92
Inspire Medical Systems
INSP
$1.46B
$8.27M 0.16%
137,225
-125,992
-48% -$9.32M
QTRX icon
93
Quanterix
QTRX
$182M
$8.19M 0.16%
445,673
+10,456
+2% +$239K
NVRO
94
DELISTED
NEVRO CORP.
NVRO
$7.99M 0.15%
79,906
-29,799
-27% -$3.58M
VEEV icon
95
Veeva Systems
VEEV
$31.7B
$7.96M 0.15%
50,884
– –
GTHX
96
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$7.96M 0.15%
721,925
– –
ZLAB icon
97
Zai Lab
ZLAB
$2.28B
$7.93M 0.15%
154,000
+33,218
+28% +$1.73M
LVGO
98
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$7.74M 0.15%
271,232
+88,658
+49% +$2.3M
PHR icon
99
Phreesia
PHR
$662M
$7.59M 0.15%
360,998
+89,953
+33% +$2.47M
VCRA
100
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$7.45M 0.14%
350,724
+46,581
+15% +$1.06M
2 3
4
5 6

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q1 2020 Portfolio in Review

As of Q1 2020, Bellevue Group held 232 positions worth $5.16B, down 18% from $6.31B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Bellevue Group's Q1 2020 filing shows 16 new, 80 increased, 52 reduced and 17 closed positions. Its largest new stake was Black Diamond Therapeutics: 1,330,000 shares worth $33.2M. The largest sale was Teladoc Health, an estimated $63.8M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Technology and Industrials.

  • Bellevue Group's largest Q1 2020 buy was Black Diamond Therapeutics: 1,330,000 shares worth $33.2M.
  • Bellevue Group added most to Fate Therapeutics in Q1 2020, an estimated $37.4M increase.
  • Bellevue Group's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $63.8M.
  • Bellevue Group fully exited Wright Medical Group Inc in Q1 2020, selling an estimated $17.1M.
  • Bellevue Group's ten largest holdings make up 41% of its $5.16B portfolio in Q1 2020.
  • Bellevue Group opened 16 new positions and closed 17 in Q1 2020.
  • Bellevue Group's portfolio value fell 18% quarter-over-quarter to $5.16B.

Based on Bellevue Group's 13F filing for Q1 2020, filed 14 May 2020.